Generate a tailored SOP for Dr. Hiran Prag. Improve your application with a focused, well-structured draft.
Hiran Prag is a Lecturer in Clinical Pharmaceutical Science at the University of Manchester. He holds a Doctor of Philosophy from the University of Cambridge and a Master of Pharmacy from the University of Nottingham. His research focuses on understanding the mechanisms of diseases caused by mitochondrial dysfunction. Prag's PhD research involved developing novel inhibitors for mitochondrial enzyme succinate dehydrogenase, which plays a critical role in cellular energy production and is associated with various diseases. His postdoctoral work at the University of Cambridge under Professor Thomas Krieg focused on ischaemia/reperfusion injury and developing therapeutic strategies to mitigate damage caused by heart attacks and organ transplantation. Currently, Prag is investigating mitochondrial metabolism and redox status in disease, aiming to identify new therapeutic targets. He is committed to contributing to educational goals linked to the United Nations Sustainable Development Goals.
University of Manchester • Manchester, England
Lecturer in Clinical Pharmaceutical Science, focusing on mitochondrial metabolism research.
Includes MSc in Advanced Electrical Power Systems and MSc in Communications and Signal Processing.